Individuals with frailty are at particular risk in emergencies. By definition, these individuals are not resilient, meaning that they do not recover quickly from stressors.
1Individuals with frailty, even in usual times, are at greater risk than nonfrail, similarly aged adults of requiring hospital care or long-term care and of dying.
- Morley J.E.
- Vellas B.
- van Kan G.A.
- et al.
Frailty consensus: A call to action.
J Am Med Dir Assoc. 2013; 14: 392-397
2Emergency preparedness involves planning for the optimal direction of resources, such as populations with the greatest needs or with the most difficulty accessing resources in an emergency. The Pandemic and All Hands Preparedness Act of 2006 required the US Department of Health and Human Services to integrate the needs of at-risk individuals in all levels of emergency planning.
- Cesari M.
- Prince M.
- Thiyagarajan J.A.
- et al.
Frailty: An emerging public health priority.
J Am Med Dir Assoc. 2016; 17: 188-192
3The challenge is knowing where these individuals are concentrated so that their needs can be met.
Pandemic and all-hazards preparedness Act, pub L No. 109-417, 120 stat 2831.
Date accessed: September 24, 2020
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the American Medical Directors Association
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Frailty consensus: A call to action.J Am Med Dir Assoc. 2013; 14: 392-397
- Frailty: An emerging public health priority.J Am Med Dir Assoc. 2016; 17: 188-192
- Pandemic and all-hazards preparedness Act, pub L No. 109-417, 120 stat 2831.(Available at:)https://www.congress.gov/bill/109th-congress/senate-bill/3678Date: 2006Date accessed: September 24, 2020
- External validation of the claims-based frailty index in the national health and aging trends study cohort.Am J Epidemiol. 2017; 186: 745-747
- Development of a claims-based frailty indicator anchored to a well-established frailty phenotype.Med Care. 2017; 55: 716-722
- CDC wonder.(Available at:)https://wonder.cdc.gov/Date: 2020Date accessed: December 6, 2020
- Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: Evidence and recommendations.Pharmacoepidemiol Drug Saf. 2014; 23: 891-901
- Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study.J Gerontol A Biol Sci Med Sci. 2019; 74: 1271-1276
- Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation.J Am Heart Assoc. 2018; 7: e008643
- Effectiveness and safety of rivaroxaban versus warfarin in frail patients with venous thromboembolism.Am J Med. 2018; 131: 933-938.e931
Published online: June 16, 2021
The authors declare no conflicts of interest.
© 2021 AMDA - The Society for Post-Acute and Long-Term Care Medicine.